{"transactions":[{"id":957884,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-29T16:01:18.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":54421,"price":2.03,"value":110474.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person acquired 54,421 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025."}],"balance_after":54426,"source":{"system":"sec-edgar","filing":"0001493152-25-029353","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000149315225029353/ownership.xml","form_type":"4"}},{"id":1173130,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:24.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0.059,"value":66.375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":610.24,"exercise_date":"2019-01-22","expiration_date":"2026-01-22","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001641172-25-003822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000164117225003822/ownership.xml","form_type":"4"}},{"id":1173129,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:24.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0.059,"value":147.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":72,"exercise_date":"2019-09-13","expiration_date":"2026-09-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001641172-25-003822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000164117225003822/ownership.xml","form_type":"4"}},{"id":1173128,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:24.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0.059,"value":66.375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":34.32,"exercise_date":"2020-02-17","expiration_date":"2027-02-17","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001641172-25-003822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000164117225003822/ownership.xml","form_type":"4"}},{"id":1173127,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:24.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0.059,"value":73.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":25.72,"exercise_date":"2020-09-16","expiration_date":"2027-09-16","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001641172-25-003822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000164117225003822/ownership.xml","form_type":"4"}},{"id":1173126,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:24.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0.059,"value":44.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":684.8,"exercise_date":"2017-10-23","expiration_date":"2027-10-23","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001641172-25-003822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000164117225003822/ownership.xml","form_type":"4"}},{"id":1173125,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-11T16:15:24.000Z","date":"2025-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1750,"price":0.059,"value":103.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation."}],"balance_after":0,"derivative":{"exercise_price":684.8,"exercise_date":"2017-12-11","expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001641172-25-003822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000164117225003822/ownership.xml","form_type":"4"}},{"id":1387979,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-10T16:05:10.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.105,"expiration_date":"2034-10-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-040727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000149315224040727/ownership.xml","form_type":"4"}},{"id":1672649,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T16:15:56.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027."}],"balance_after":75000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-003451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000149315224003451/ownership.xml","form_type":"4"}},{"id":2049382,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-20T16:05:51.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026."}],"balance_after":40000,"derivative":{"exercise_price":1.61,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-002023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000149315223002023/ownership.xml","form_type":"4"}},{"id":2161986,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common stock","published_at":"2022-09-09T09:00:10.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":150,"price":2.62,"value":393.0,"ownership":{"direct":true},"balance_after":150,"source":{"system":"sec-edgar","filing":"0001493152-22-025450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000149315222025450/ownership.xml","form_type":"4"}},{"id":2422153,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-28T16:30:25.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":45850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months."}],"balance_after":45850,"derivative":{"exercise_price":4.9,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":45850},"source":{"system":"sec-edgar","filing":"0001493152-22-002550","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000149315222002550/ownership.xml","form_type":"4"}},{"id":2611095,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-06T17:00:42.000Z","date":"2021-08-04","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months."}],"balance_after":210000,"derivative":{"exercise_price":8.87,"expiration_date":"2031-08-04","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001493152-21-018911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1648585/000149315221018911/ownership.xml","form_type":"4"}},{"id":3026540,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-18T17:01:25.000Z","date":"2020-09-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in full on December 31, 2021."}],"balance_after":100000,"derivative":{"exercise_price":0.3215,"expiration_date":"2027-09-16","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-20-027391","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638381/000121390020027391/ownership.xml","form_type":"4"}},{"id":3261874,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T21:45:41.000Z","date":"2020-02-17","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on February 17, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through February 17, 2023."}],"balance_after":90000,"derivative":{"exercise_price":0.4287,"expiration_date":"2027-02-17","underlying":"Ordinary Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001213900-20-004341","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638381/000121390020004341/ownership.xml","form_type":"4"}},{"id":3413496,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-16T21:28:57.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on September 13, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through September 13, 2022."}],"balance_after":200000,"derivative":{"exercise_price":0.9,"expiration_date":"2026-09-13","underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-19-018235","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638381/000121390019018235/ownership.xml","form_type":"4"}},{"id":3689089,"issuer":{"id":146542,"kind":"organization","name":"Intec Pharma Ltd.","symbol":"NTEC"},"owners":[{"id":70808,"kind":"person","name":"Linscott Walt Addison","position":1,"cik":"0001648585","reported_name":"Linscott Walt Addison","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-23T16:14:39.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2020 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through January 22, 2022."}],"balance_after":90000,"derivative":{"exercise_price":7.628,"expiration_date":"2026-01-22","underlying":"Ordinary Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001213900-19-001108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638381/000121390019001108/ownership.xml","form_type":"4"}}]}